(E)-3-(2,6-dimethoxybenzylidene)indolin-2-one | 1148118-90-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-3-(2,6-dimethoxybenzylidene)indolin-2-one
• 英文别名: (3E)-3-[(2,6-dimethoxyphenyl)methylidene]-1H-indol-2-one
• CAS: 1148118-90-4
• 化学式: C₁₇H₁₅NO₃
• 分子量: 281.311
• InChiKey: CVEGVKQNWFGKPA-ZRDIBKRKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-3-(2,6-dimethoxybenzylidene)indolin-2-one 以 氘代乙腈 为溶剂， 生成 3-(2,6-dimethoxybenzylidene)indolin-2-one
  参考文献：
  名称：

  高效羟吲哚基分子光电开关

  摘要：

  3-亚苄基-二氢吲哚-2-酮对于制药工业非常重要。这些化合物的生物学特性已被广泛报道，但几乎没有对其光化学活性进行研究。在这里，我们提出了 3-亚苄基-二氢吲哚-2-酮作为一类有前途的光开关，具有高产率、强大的光化学开关和高达 50% 的量子产率。

  DOI：

  10.1002/chem.202301634
• 作为产物：
  描述：

  2-吲哚酮 、 2,6-二甲氧基苯甲醛 在 哌啶 作用下， 以 乙醇 为溶剂， 以99 %的产率得到(E)-3-(2,6-dimethoxybenzylidene)indolin-2-one
  参考文献：
  名称：

  高效羟吲哚基分子光电开关

  摘要：

  3-亚苄基-二氢吲哚-2-酮对于制药工业非常重要。这些化合物的生物学特性已被广泛报道，但几乎没有对其光化学活性进行研究。在这里，我们提出了 3-亚苄基-二氢吲哚-2-酮作为一类有前途的光开关，具有高产率、强大的光化学开关和高达 50% 的量子产率。

  DOI：

  10.1002/chem.202301634

文献信息

• [EN] NOVEL THERAPEUTIC USE OF INDOLINONE DERIVATIVES<br/>[FR] NOUVELLE UTILISATION THERAPEUTIQUE DE DERIVES D'INDOLINONE
  申请人：LEO PHARMA AS

  公开号：WO2005058309A1

  公开（公告）日：2005-06-30

  Certain oxindole compounds have been found to be effective in experimentally induced autoimmune encephalitis and are therefore suggested for the preparation of a medicament for the prevention, treatment or amelioration of multiple sclerosis, or to delay the onset of or reduce the relapse rate in multiple sclerosis.

  某些氧吲哚化合物已被发现在实验诱导的自身免疫性脑炎中具有有效性，因此建议用于制备用于预防、治疗或改善多发性硬化症的药物，或延缓多发性硬化症的发作或减少复发率。
• Novel therapeutic use
  申请人：Bouerat Duvold Maud Elysa Laetitia

  公开号：US20070167488A1

  公开（公告）日：2007-07-19

  Certain oxindole compounds have been found to be effective in experimentally induced autoimmune encephalitis and are therefore suggested for the preparation of a medicament for the prevention, treatment or amelioration of multiple sclerosis, or to delay the onset of or reduce the relapse rate in multiple sclerosis.

  某些恶唑酮化合物已被发现在实验性自身免疫脑炎中具有疗效，因此建议用于制备用于预防、治疗或改善多发性硬化症的药物，或者延迟多发性硬化症的发作或减少复发率。
• Functionalized 3-benzylidene-indolin-2-ones: Inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity
  作者：Wei Zhang、Mei-Lin Go

  DOI：10.1016/j.bmc.2008.12.052

  日期：2009.3

  Functionalized benzylidene-indolin-2-ones are widely associated with antiproliferative activity. The scaffold is not normally associated with chemoprevention in spite of the presence of a nitrogen-linked Michael acceptor moiety that may predispose members to induction of NQO1, a widely used biomarker of chemopreventive potential. To investigate this possibility, we have synthesized and evaluated a series of functionalized 3-benzylidene-indolin-2-ones for induction of NQO1 in murine Hepa1c1c7 cells as well as antiproliferative activity against two human cancer cell lines (MCF-7, HCT116). The benzylideneindolinones were found to be good inducers of NQO1 activity, with 85% of test compounds able to increase basal NQO1 activity by more than twofold at concentrations of <= 10 mu M. By contrast, fewer compounds (11%) tested at the same concentration were able to reduce cell viability by more than 50%. Structure activity relationships showed that the nitrogen linked Michael acceptor moiety was an essential requirement for both activities. This common feature notwithstanding, substitution of the 3-benzylidene-indolin-2-one core structure affected NQO1 induction and antiproliferative activities in dissimilar ways, underscoring different structural requirements for these two activities. Nonetheless, promising compounds ( 10, 42, 45-48) were identified that combine selective induction of NQO1 with potent antiproliferative activity. A potential advantage of such agents would be the ability to provide added protection to normal cells by the up-regulation of NQO1 and other phase II enzymes while simultaneously targeting neoplastic cells. (C) 2008 Elsevier Ltd. All rights reserved.
• NOVEL THERAPEUTIC USE OF INDOLINONE DERIVATIVES
  申请人：LEO PHARMA A/S

  公开号：EP1696906A1

  公开（公告）日：2006-09-06
• Highly Efficient Oxindole‐Based Molecular Photoswitches
  作者：Daniel Doellerer、Daisy R. S. Pooler、Ainoa Guinart、Stefano Crespi、Ben L. Feringa

  DOI：10.1002/chem.202301634

  日期：2023.10.2

  extensively reported for their biological properties, but have hardly been studied concerning their photochemical activity. Here, we present 3-benzylidene-indoline-2-ones as a promising class of photoswitches with high yields, robust photochemical switching, and quantum yields reaching up to 50 %.

  3-亚苄基-二氢吲哚-2-酮对于制药工业非常重要。这些化合物的生物学特性已被广泛报道，但几乎没有对其光化学活性进行研究。在这里，我们提出了 3-亚苄基-二氢吲哚-2-酮作为一类有前途的光开关，具有高产率、强大的光化学开关和高达 50% 的量子产率。